1. Vashishtha Vipin M
2. Srirampur Sanjay
3. Nagar Pritesh

9789390020607

10.5005/jp/books/18508_31

3/e

2021

19

1. Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices; , Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, National Convener, IAP Committee on Immunization, 2011-13, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India; Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices
2. Aditya Hospital, Hyderabad, Andhra Pradesh, India, Aditya Superspeciality Hospitals, Hyderabad, Telengana, India, Aditya Hospital, Hyderabad, Telangana, India, Aditya Superspecialty Hospital, Hyderabad, Telangana, India
3. Aditya Hospital, Hyderabad, Andhra Pradesh, India, Aditya Hospital, Tilak Road, Mumbai, Maharashtra, India, Aditya Hospital, Hyderabad, Telangana, India

Influenza Vaccine, ribonucleic acid, flu cause, antigenic shift, antigenic drift, acute respiratory distress syndrome (ARDS, complication, acute respiratory infection, ARI, trivalent inactivated vaccine, TIV, quadrivalent influenza vaccine, QIV, live attenuated influenza vaccine, LAIV